Sign In
Buy ZEAL
$17.59
+0 (+0%)
At Close: Jan 27, 2023
New Employee Elected Directors to the Board of Zealand Pharma A/S
05:00pm, Wednesday, 13'th Mar 2024
Company announcement – No. 14 / 2024 New Employee Elected Directors to the Board of Zealand Pharma A/S Copenhagen, Denmark, March 13, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-
Company announcement – No. 13 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenh
The Emergence of Strong Weight Loss Drug Players
05:44pm, Tuesday, 05'th Mar 2024
Viking Therapeutics (VKTX) and Zealand Pharma report a successful phase 2 for weight loss drugs. Maurits Pot discusses the emergence of strong weight loss drug players.
Company announcement – No. 12 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenh
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
04:00pm, Tuesday, 05'th Mar 2024
Company announcement – No. 11 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 5, 2024 – Zealand Pharma A/S (“Zealan
Zealand Pharma to Participate in TD Cowen's 44th Annual Health Care Conference
11:00am, Friday, 01'st Mar 2024
Press release – No. 3 / 2023 Zealand Pharma to Participate in TD Cowen's 44th Annual Health Care Conference Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR
Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript
11:51am, Tuesday, 27'th Feb 2024
Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript
Zealand Pharma Announces Financial Results for the Full Year 2023
01:00am, Tuesday, 27'th Feb 2024
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a solid f
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
02:00am, Tuesday, 20'th Feb 2024
Press Release – No. 2 / 2024 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results Copenhagen, Denmark, February 20, 2024 – a Zealand Pha
Zealand Pharma A/S (ZEAL) Q3 2023 Earnings Call Transcript
12:15pm, Friday, 10'th Nov 2023
Zealand Pharma A/S (ZEAL) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Anna Krassowska - Vice President-Investor Relations Adam Steensberg - President & Chief Exec
Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
11:05am, Monday, 14'th Aug 2023
Press Release – No. 9 / 2023 Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results Copenhagen, Denmark, August 14, 2023 – a Zealand Pharma A/
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
11:05am, Thursday, 04'th May 2023
Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a Zealand Pharma A/S (CVR
Zealand Pharma A/S (ZEAL) Q4 2022 Earnings Call Transcript
12:55pm, Thursday, 02'nd Mar 2023
Zealand Pharma A/S (ZEAL) Q4 2022 Results Conference Call March 1, 2022 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - President, CEO Henriette Wennicke - CFO David Kendall
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
01:00am, Friday, 24'th Feb 2023
Press release – No. 1 / 2023
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Call Transcript
04:42pm, Friday, 11'th Nov 2022
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Anna Krassowska - Vice President, Investor Relations & Corporate Communications Adam Steen
